NOT-DA-19-004: Notice of NIDA's participation in PAR-18-836 "Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)"

Notice of NIDA's participation in PAR-18-836 "Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)"

Notice Number: NOT-DA-19-004

Key Dates
Release Date: October 23, 2018

Related Announcements
PAR-18-836

Issued by
National Institute on Drug Abuse (NIDA)

Purpose

The following changes have been made to reflect NIDA's participation in this FOA:

Part 1. Overview Information

Components of Participating Organizations

Fogarty International Center (FIC)

National Institute on Aging (NIA)

National Institute on Deafness and Other Communication Disorders (NIDCD)

National Institute on Environmental Health Sciences (NIEHS)

National Institute of Mental Health (NIMH)

National Institute of Neurological Disorders and Stroke (NINDS)

National Eye Institute (NEI)

National Institute of Dental and Craniofacial Research (NIDCR)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute on Drug Abuse ( NIDA)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.121, 93.989, 93.866, 93.113, 93.853, 93.867, 93.173, 93.242, 93.865, 93.279

Section VII. Agency Contacts

The following contacts have been added:

Scientific/Research Contact(s)

Steve Gust, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301.402.1118
Email: [email protected]

Financial/Grants Management Contact(s)

Pam Fleming
National Institute on Drug Abuse (NIDA)
Telephone: 301-480-1159
Email: [email protected]

Inquiries

Please direct all inquiries to:

Steve Gust, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-402-1118
Email: [email protected]